Results 161 to 170 of about 13,936 (245)

Seroprevalence of equine leptospirosis in Poland (2019–2023)

Equine Veterinary Journal, Volume 58, Issue 2, Page 523-532, March 2026.
Abstract Background Leptospirosis in horses is associated with various clinical signs, potentially leading to fatal outcomes. Additionally, the disease may pose a zoonotic risk to individuals involved in handling infected animals. Implementing a serological monitoring programme in the equine population is one of the key tools used to reduce the risk of
Jacek Żmudzki, Monika Ostrowska, Zbigniew Arent, Maciej Frant, Maciej Kochanowski, Agnieszka Nowak, Sylwia Zębek, Damian Kalinowski, Katarzyna Podgórska   +8 more
wiley   +1 more source

Causes of Visual Loss in Uveitis: A Retrospective Study at a Tertiary Referral Centre. [PDF]

Cureus
Al-Roubaie M, Beare N.
europepmc   +1 more source

Sex Matters: Hormonal and Chromosomal Determinants of Autoimmunity and Anti‐Cancer Immunity Across the Lifespan

Immunological Reviews, Volume 338, Issue 1, March 2026.
ABSTRACT Sex plays a key role in shaping both anti‐cancer immunity and autoimmunity. Biological factors underlying sexual dimorphism have now been identified in multiple aspects of anti‐cancer immunity and autoimmunity. These factors include sex differences in hormone levels, chromosome complement, and expression of the long non‐coding RNA XIST.
Christian G. Bustillos, Esther M. Peluso, Sophia L. Cha, Melissa G. Lechner, Maureen A. Su   +4 more
wiley   +1 more source

Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma

Veterinary and Comparative Oncology, Volume 24, Issue 1, Page 51-57, March 2026.
ABSTRACT Mechlorethamine is commonly prescribed to dogs at 3 mg/m2. The minimal toxicity observed indicates that higher doses of mechlorethamine are likely tolerable. The primary objective of this study was to determine the maximally tolerated dose (MTD) of mechlorethamine in dogs with lymphoma.
Laura E. Chadsey, Paul R. Hess, Joanne L. Intile   +2 more
wiley   +1 more source

Management of Haws Syndrome in Cats With Gastrointestinal Diet: A Case Series

Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.
ABSTRACT Background Haws syndrome (HS) in cats is characterized by bilateral protrusion of the third eyelid and ptosis, often accompanied by gastrointestinal (GI) symptoms such as diarrhea. Emerging evidence suggests disruption of the gut‐brain axis, linked to GI microbiota dysbiosis, may play a role in HS development.
Bar Fruchter, Sharon Kuzi, Yamit Soueid, Oren Pe'er, Ron Ofri, Lionel Sebbag   +5 more
wiley   +1 more source

Rates of Drug-Induced Uveitis: A Review by Medication Class. [PDF]

Clin Ophthalmol
Jasti R, Wang Z, Zhou L, Nguyen BV, Berkenstock MK.   +4 more
europepmc   +1 more source

Cell and Gene Therapy in Equine Ocular Disease

Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.
ABSTRACT Equine ocular disease is common and often challenging to treat using traditional methods. This has led to the development of new therapies. Like human medicine, veterinary medicine is adopting cellular and gene therapy as innovative approaches. Equine ocular disease is a particularly promising area for these techniques.
Kimberly A. S. Young, Lauren V. Schnabel, Brian C. Gilger   +2 more
wiley   +1 more source

Etiologies of intermediate uveitis in a tertiary center: an age-oriented medical assessment? [PDF]

J Ophthalmic Inflamm Infect
Mansuy P, El-Jammal T, Jacquot R, Mathis T, Kodjikian L, Sève P.   +5 more
europepmc   +1 more source

Bilateral acute intermediate uveitis following intrauterine Chitosan tamponade: a case series. [PDF]

J Ophthalmic Inflamm Infect
Beckers D, Pleyer U, Beckers L, Maul H, Lüder M, Schaudig U, Stemplewitz B.   +6 more
europepmc   +1 more source

Ultrasound biomicroscopy findings in uveitic hypotony: a three-case report. [PDF]

BMC Ophthalmol
Hachimi RE, Laarif Y, Arari NE, Benchekroune S, Boutimzine N, Cherkaoui LO.   +5 more
europepmc   +1 more source